ClinicalCodes.org

An online clinical codes repository to improve validity and reproducibility of medical database research

Research article:

Breast and cervical cancer screening utilization, and recording bias, in women with type 2 diabetes (UK)

Reference:

Matthew Carr, Evan Kontopantelis, Tim Doran, Christine Campbell, Lorraine Lipscombe, Emma Crosbie, Anthony Howell, Iain E Buchan, Andrew G Renehan (2015) Breast and cervical cancer screening utilization, and recording bias, in women with type 2 diabetes (UK). Diabetologia, doi:

Link to article
Abstract
Aims/hypothesis: Studies from healthcare databases suggest that patients with type 2 diabetes (T2D) under-utilize cancer screening opportunities, but recording bias may be a problem. We evaluated the relative effect of T2D on screening utilization trends among long-established UK national programmes in breast and cervical cancers; and tested the impact of introducing a primary care financial incentive scheme (QOF) in 2004, known to improve data recording for diabetes-related care. Materials and methods: Using the Clinical Practice Research Datalink, we identified women with prevalent T2DM (N = 174,256), separately by year for 1999 to 2011, and eligible for screening events for breast (aged 50-70 years) and cervical (aged 35-49 and 50-64 years) cancers. We described secular trends and compared these with the non-diabetes population, and accounted for co-morbidities using matched conditional logistic regression models. We performed interrupted time-series (ITS) analyses to assess the impact of the QOF introduction. Results: Compared with the non-diabetes population, relative uptake rates for breast and cervical screening were generally similar in patients with T2D pre-2004, becoming greater for years post-2004. These patterns were unaffected by adjustment for GP practice, and were not accounted for by T2D associated co-morbidities. ITS analysis showed increased activities in all three screening groups for 2007, but these broadly returned to pre-2004 trends by 2011, paralleling similar patterns in recording for other care provision indicators. Conclusions/interpretation: In this population, we found no evidence that women with T2D under-utilize breast and cervical cancer screening opportunities. A financial incentive scheme was associated with intermediate-term improvements in screening utilization, but this is likely to reflect improved recording of care events.
Author for correspondence
Andrew Renehan
Email for correspondence
arenehan@picr.man.ac.uk

Code list: res22: screen_cervical

91 codes in list

Code Coding system Description Entity type List name
4149.00 Read Cervical cytology sample sent to laboratory test res22: screen_cervical
4JRL.00 Read Cervical cytology screening test test res22: screen_cervical
4K2..00 Read Cervical smear result test res22: screen_cervical
4K21.00 Read Cervical smear:inadequate spec test res22: screen_cervical
4K2..11 Read Dyskaryosis on cervical smear test res22: screen_cervical
4K2..12 Read Dysplasia (dysk.)on cerv.smear test res22: screen_cervical
4K22.00 Read Cervical smear: negative test res22: screen_cervical
4K22.11 Read Smear NAD: no endocervic cells test res22: screen_cervical
4K23.00 Read Cerv.smear: mild dyskaryosis test res22: screen_cervical
4K24.00 Read Cerv.smear: severe dyskaryosis test res22: screen_cervical
4K25.00 Read Cerv.smear:severe dysk.?inv.ca test res22: screen_cervical
4K26.00 Read Cervical smear: ? gland neopl. test res22: screen_cervical
4K27.00 Read Cervical smear:atrophic change test res22: screen_cervical
4K27.11 Read Atrophic change on cerv.smear test res22: screen_cervical
4K28.00 Read Cerv.smear: mod.dyskaryosis test res22: screen_cervical
4K29.00 Read Cerv.smear: borderline changes test res22: screen_cervical
4K2A.00 Read Cervical smear endocervical cells present test res22: screen_cervical
4K2B.00 Read Cervical smear endocervical cells absent test res22: screen_cervical
4K2C.00 Read Smear NAD - no endocervical cells test res22: screen_cervical
4K2D.00 Read Cervical smear transformation zone cells present test res22: screen_cervical
4K2E.00 Read Cervical smear transformation zone cells absent test res22: screen_cervical
4K2F.00 Read test res22: screen_cervical
4K2Z.00 Read Cervical smear result NOS test res22: screen_cervical
4K2Z.11 Read Nuclear abnormality on smear test res22: screen_cervical
4K3..00 Read Cervical smear - inflam.change test res22: screen_cervical
4K31.00 Read Cervical smear-no inflammation test res22: screen_cervical
4K32.00 Read Cervical smear-severe inflamm. test res22: screen_cervical
4K33.00 Read Cervical smear - trichomonas test res22: screen_cervical
4K34.00 Read Cervical smear - candida test res22: screen_cervical
4K35.00 Read Cerv.smear - viral infl.unsp. test res22: screen_cervical
4K35.11 Read Viral changes on cerv. smear test res22: screen_cervical
4K36.00 Read Cervical smear - wart virus test res22: screen_cervical
4K36.12 Read HPV changes: cervical smear test res22: screen_cervical
4K3A.00 Read Cervical smear: koilocytosis test res22: screen_cervical
4K3B.00 Read Cervical smear - mild inflammation test res22: screen_cervical
4K3C.00 Read Cervical smear - moderate inflammation test res22: screen_cervical
4K3Z.00 Read Cervical smear - inflam. NOS test res22: screen_cervical
4K4..00 Read Cervical smear - action needed test res22: screen_cervical
4K48.00 Read Cx. smear: colposcopy needed test res22: screen_cervical
4K49.00 Read Cx. smear:cervical biopsy need test res22: screen_cervical
4K4Z.00 Read Cervical smear action NOS test res22: screen_cervical
4K55.00 Read Cervical cytology test test res22: screen_cervical
4KA..00 Read Vaginal vault smear result test res22: screen_cervical
4KA1.00 Read Vaginal vault smear negative test res22: screen_cervical
4KA4.00 Read Vaginal vault smear abnormal test res22: screen_cervical
685..00 Read Cervical neoplasia screening test res22: screen_cervical
685..11 Read Cervical cytology screen test res22: screen_cervical
685..12 Read Cervical smear screen test res22: screen_cervical
6859.00 Read Ca cervix - screen done test res22: screen_cervical
6859.11 Read Cervical cytology examination test res22: screen_cervical
685A.00 Read Ca cervix screen-no result yet test res22: screen_cervical
685B.00 Read Ca cervix screen normal test res22: screen_cervical
685C.00 Read Ca cervix screen abnormal test res22: screen_cervical
685D.00 Read Ca cervix screen + fee claim test res22: screen_cervical
685E.00 Read Cervical smear status unknown test res22: screen_cervical
685R.00 Read Liquid based cervical cytology screening test res22: screen_cervical
685Z.00 Read Ca cervix screen NOS test res22: screen_cervical
7E2A000 Read Exam female genital tract under anaesth & Papanicolau smear test res22: screen_cervical
7E2A200 Read Papanicolau smear NEC test res22: screen_cervical
7E2A211 Read Cervical smear NEC test res22: screen_cervical
7E2A300 Read Vaginal vault smear test res22: screen_cervical
981..00 Read FP74 - cervical cytology claim test res22: screen_cervical
981..11 Read Cervical smear - fee claim test res22: screen_cervical
9O81.00 Read Cervical smear - 1st call test res22: screen_cervical
9O8A.00 Read Abnormal smear - 1st recall test res22: screen_cervical
9O8R.00 Read Smear normal - pt. notified test res22: screen_cervical
9O8T.00 Read Cervical smear slide lost in transit test res22: screen_cervical
9O8U.00 Read Cervical smear slide broken in transit test res22: screen_cervical
9O8V.00 Read Place cervical smear taken test res22: screen_cervical
R150.00 Read [D]Nonspecific abnormal Papanicolaou cervical smear test res22: screen_cervical
R150000 Read [D]Dyskaryotic cervical smear test res22: screen_cervical
R150100 Read [D] Koilocytosis - cervical smear test res22: screen_cervical
R150.11 Read [D]Cervical smear - nonspecific abnormality test res22: screen_cervical
R150.12 Read [D]Papanicolaou smear - nonspecific abnormality test res22: screen_cervical
R150z00 Read [D]Nonspecific abnormal Papanicolaou cervical smear NOS test res22: screen_cervical
R151.00 Read [D]Nonspecific abnormal Papanicolaou smear of other origin test res22: screen_cervical
ZV76200 Read [V]Screening for malignant neoplasm of cervix test res22: screen_cervical
ZV76211 Read [V]Routine Papanicolaou smear test res22: screen_cervical
ZV76212 Read [V]Routine cervical smear test res22: screen_cervical
9O89.00 OXMIS SMEAR ABNORMAL - PATIENT TOLD test res22: screen_cervical
9O89.11 OXMIS SMEAR ABNORMAL - PT. NOTIFIED test res22: screen_cervical
L3230T OXMIS CERVICAL SMEAR TAKEN test res22: screen_cervical
L9160 OXMIS PAP SMEAR EXAMINATION test res22: screen_cervical
L9160NG OXMIS PAP SMEAR NEGATIVE test res22: screen_cervical
L9161AC OXMIS CERVICAL SMEAR ABNORMAL test res22: screen_cervical
L9162 OXMIS CERVICAL SMEAR test res22: screen_cervical
L9162BA OXMIS SMEAR INFLAMED test res22: screen_cervical
L9162N OXMIS NEGATIVE - CERVICAL SMEAR test res22: screen_cervical
L9162PJ OXMIS CARCINOMA IN SITU - CERVICAL SMEAR test res22: screen_cervical
L9162PP OXMIS CERVICAL SMEAR CIN I test res22: screen_cervical
L9162PQ OXMIS CERVICAL SMEAR CIN II test res22: screen_cervical

0 comments have been posted.

Please log in to leave a comment.